CD44 has been identified as a potential CSC marker in CRC [40] and has also been shown to be a more selective colon CSC marker than CD133 since decreased expression of CD44, but not CD133, has been shown to reduce both clonal formation and tumor formation [41]. The gene discussed is CD44; the disease is neoplasm.